Claims
- 1. A compound of formula Ia ##STR12## wherein R.sup.1a is C.sub.1-6 -alkyl optionally substituted with halogen; C.sub.2-6 -alkenyl; C.sub.2-6 alkynyl; C.sub.3-6 -cycloalkyl; C.sub.1-6 -alkyl substituted with C.sub.3-6 -cycloalkyl; carboxy; --COR.sup.10a ; --COOR.sup.10a ; C.sub.1-6 -alkyl substituted with dimethylamino; --R.sup.10a --O--R.sup.11a ; --R.sup.10a --O--R.sup.11a --O--R.sup.12a ; phenylsulfonyl benzoyl; benzyl; or phenyl; each of which aromatic groups is optionally substituted with C.sub.1-6 -alkyl, C.sub.1-6 -alkoxy, halogen, carboxy or nitro; wherein R.sup.10a, R.sup.11a, and R.sup.12a are independently C.sub.1-6 -alkyl;
- R.sup.2a is halogen; C.sub.1-6 -alkyl substituted with C.sub.3-6 -cycloalkyl; C.sub.3-6 -cycloalkyl; C.sub.2-6 -alkenyl; C.sub.2-6 -alkynyl; benzyl; C.sub.1-6 -alkyl substituted with dimethylamino; --R.sup.10a --O--R.sup.11a ; --R.sup.10a --O--R.sup.11a --O--R.sup.12a ; wherein R.sup.10a, R.sup.11a and R.sup.12a are independently C.sub.1-6 -alkyl; --O substituted with C.sub.3-6 -cycloalkyl, C.sub.2-6 -alkenyl, C.sub.2-6 -alkynyl, phenyl, benzyl, C.sub.1-6 -alkyl substituted with C.sub.3-6 -cycloalkyl or dimethylamino, --R.sup.10a --O--R.sup.11a, --R.sup.10a --O--R.sup.11a --O--R.sup.12a, wherein R.sup.10a, R.sup.11a and R.sup.12a are independently C.sub.1-6 -alkyl; --S substituted with C.sub.1-6 alkyl, C.sub.3-6 -cycloalkyl, C.sub.2-6 -alkenyl, C.sub.2-6 -alkynyl, phenyl, benzyl, C.sub.1-6 -alkyl substituted with C.sub.3-6 -cycloalkyl or dimethylamino, --R.sup.10a --O--R.sup.11a, --R.sup.10a --O--R.sup.11a --O--R.sup.12a, wherein R.sup.10a, R.sup.11a and R.sup.12a are independently C.sub.1-6 -alkyl; --N substituted with one or two C.sub.1-6 -alkyl which alkyl group(s) is/are optionally substituted with hydroxy, morpholino, amino unsubstituted or N-mono or disubstituted with C.sub.1-6 -alkyl, phenyl, phenyl-sulfonyl or benzyl; morpholino; piperidino; or piperazino optionally N-substituted with C.sub.1-6 -alkyl;
- R.sup.3a and R.sup.4a are independently H; --CN; --COR.sup.13a ; --COOR.sup.13a ; --SOR.sup.13a ; or --SO.sub.2 R.sup.13a ; wherein R.sup.13a is C.sub.1-6 -alkyl optionally substituted with C.sub.3-6 -cycloalkyl, C.sub.3-6 -cycloalkyl, C.sub.2-6 -alkenyl, C.sub.2-6 -alkynyl, phenyl, benzyl, C.sub.1-6 -alkyl substituted with dimethylamino, --R.sup.10a --O--R.sup.11a or --R.sup.10a --O--R.sup.11a --O--R.sup.12a wherein R.sup.10a, R.sup.11a and R.sup.12a are independently C.sub.1-6 -alkyl; --NH substituted with --COR.sup.14a wherein R.sup.14a is H or C.sub.1-6 -alkyl; --CONH optionally substituted with H or C.sub.1-6 -alkyl; or 1-methyl-2-imidazolyl; provided that R.sup.3a and R.sup.4a cannot both be H;
- R.sup.5a is H or C.sub.1-6 -alkyl; provided that R.sup.5a is not H when either R.sup.3a or R.sup.4a is H; and
- R.sup.6a, R.sup.7a, R.sup.8a and R.sup.9a are independently H; nitro; amino; halogen; trifluoromethyl; trifluoroacetyl; sulfo; carboxy; carbamoyl; sulfamoyl; --COR.sup.10a or --COOR.sup.10a wherein R.sup.10a is as defined above; C.sub.1-6 -alkoxy; or C.sub.1-6 -alkyl optionally substituted with halogen; or a salt thereof with a pharmaceutically acceptable acid or base.
- 2. A compound according to claim 1 wherein R.sup.1a is benzyl optionally substituted with C.sub.1-6 -alkyl, C.sub.1-6 -alkoxy, halogen, carboxy or nitro.
- 3. A compound according to claim 1 wherein R.sup.3a and R.sup.4a are independently --CN; --COR.sup.13a or --COOR.sup.13a ; wherein R.sup.13a is C.sub.1-6 -alkyl optionally substituted with C.sub.3-6 -cycloalkyl, C.sub.3-6 -cycloalkyl, C.sub.2-6 -alkenyl, C.sub.2-6 -alkynyl, phenyl, benzyl, C.sub.1-6 -alkyl substituted with dimethylamino, --R.sup.10a --O--R.sup.11a or --R.sup.10a --O--R.sup.11a --O--R.sup.12a wherein R.sup.10a, R.sup.11a and R.sup.12a are independently C.sub.1-6 -alkyl.
- 4. A compound according to claim 1 which is
- Ethyl 2-cyano-3-(1-(4-chlorobenzyl)-2-chloro-3-indolyl)acrylate,
- Ethyl 2-cyano-3-(1-(3-chlorobenzyl)-2-chloro-3-indolyl)acrylate,
- Ethyl 2-cyano-3-(1-(2-chlorobenzyl)-2-chloro-3-indolyl)acrylate,
- Ethyl 2-cyano-3-(1-(4-methoxybenzyl)-2-chloro-3-indolyl)acrylate,
- Ethyl 2-cyano-3-(1-(3-methoxybenzyl)-2-chloro-3-indolyl)acrylate,
- Ethyl 2-cyano-3-(1-(2-methoxybenzyl)-2-chloro-3-indolyl)acrylate,
- Ethyl 2-ethoxycarbonyl-3-(1-(4-chlorobenzyl)-2-chloro-3-indolyl)acrylate,
- Ethyl 2-ethoxycarbonyl-3-(1-(4-methoxybenzyl)-2-chloro-3-indolyl)acrylate,
- Ethyl 2-cyano-3-(1-benzyl-2-chloro-3-indolyl)acrylonitrile,
- Ethyl 2-cyano-3-(1-(4-methoxybenzyl)-2-chloro-3-indolyl)acrylonitrile,
- Ethyl 2-cyano-3-(1-(4-chlorobenzyl)-2-chloro-3-indolyl)acrylonitrile,
- Ethyl 2-cyano-3-(1-methyl-2-chloro-3-indolyl)acrylonitrile,
- Methyl 3-(1-benzyl-2-chloro-3-indolyl)-2-methoxycarbonylacrylate,
- Methyl 3-(1-(4-methoxybenzyl)-2-chloro-3-indolyl)-2-methoxycarbonylacrylate,
- Methyl 3-(1-(4-chlorobenzyl)-2-chloro-3-indolyl)-2-methoxycarbonylacrylate,
- Methyl 3-(1-methyl-2-chloro-3-indolyl)-2-methoxycarbonylacrylate,
- 3-(1-benzyl-2-chloro-3-indolyl)-2-ethoxycarbonylacrylamide,
- 3-(1-(4-methoxybenzyl)-2-chloro-3-indolyl)-2-methoxycarbonylacrylamide,
- 3-(1-(4-chlorobenzyl)-2-chloro-3-indolyl)-2-ethoxycarbonylacrylamide,
- 2-Ethoxycarbonyl-3-(1-methyl-2-chloro-3-indolyl)acrylamide,
- 2-Ethoxycarbonyl-3-(1-benzyl-2-chloro-3-indolyl)-n-methylacrylamide,
- 2-Ethoxycarbonyl-3-(1-(4-methoxybenzyl)-2-chloro-3-indolyl)-N-methylacrylamide,
- 2-Ethoxycarbonyl-3-(1-(4-chlorobenzyl)-2-chloro-3-indolyl)-N-methylacrylamide,
- 2-Ethoxycarbonyl-3-(1-methyl-2-chloro-3-indolyl)-N-methylacrylamide, or a pharmaceutically acceptable salt thereof.
- 5. A compound according to claim 1 which is
- Ethyl 2-cyano-3-(1-methyl-2-chloro-3-indolyl)acrylate,
- 3(1-Methyl-2-chloro-3-indolyl)-2-methylsulfonyl-acrylonitrile,
- 3-(1-Benzyl-2-chloro-3-indolyl)-2-methylsulfonylacrylonitrile,
- 3-(1-Cyclopropylmethyl-2-chloro-3-indolyl)-2-(1-methyl-2-imidazolylsulfonyl) acrylonitrile,
- 3-(1-Methyl-2-chloro-3-indolyl)-2-(2-propylsulfonyl)acrylonitrile,
- 3-(1-Benzyl-2-methylthio-3-indolyl)-2-methylsulfonyl-acrylonitrile,
- or a pharmaceutically acceptable salt thereof.
- 6. A compound according to claim 1 which is Ethyl 2-cyano-3-(1-benzyl-2-chloro-3-indolyl)acrylate or a pharmaceutically acceptable salt thereof.
- 7. A pharmaceutical composition comprising a compound according to claim 1 together with a pharmaceutically acceptable carrier or diluent.
- 8. A pharmaceutical composition according to claim 7 in the form of an oral dosage unit or parenteral dosage unit.
- 9. A pharmaceutical composition according to claim 8, wherein said dosage unit comprises from about 1 to about 100 mg of a compound.
- 10. A method of treating a disease in the central nervous system via the metabotropic glutamate receptor system comprising administering to a subject in need thereof an effective amount of a compound according to claim 1.
- 11. A method according to claim 10 wherein said disease is epilepsy, senile dementia, Parkinson's disease, Huntington's Chorea, pain or deficiencies of mental and motoric performance seen after conditions of brain ischemia.
Priority Claims (2)
Number |
Date |
Country |
Kind |
0295/94 |
Mar 1994 |
DKX |
|
0870/95 |
Jul 1995 |
DKX |
|
Parent Case Info
This application is a continuation-in-part of Ser. No. 08/509,471 filed Jul. 31, 1995 which is a continuation-in-part of Ser. No. 08/403,357 filed Mar. 14, 1995, now U.S. Pat. No. 5,536,721 and a continuation of PCT/DK96/00332 filed Jul. 31, 1996, which are incorporated herein by reference by their entirety.
US Referenced Citations (4)
Number |
Name |
Date |
Kind |
3931230 |
Zinnes et al. |
Jan 1976 |
|
4952584 |
Thompson et al. |
Aug 1990 |
|
5122537 |
Buzzetti et al. |
Jun 1992 |
|
5284862 |
Bigge et al. |
Feb 1994 |
|
Foreign Referenced Citations (2)
Number |
Date |
Country |
1268772 |
Mar 1972 |
GBX |
WO 9201670 |
Feb 1992 |
WOX |
Non-Patent Literature Citations (6)
Entry |
Chemical Abstracts, 19525 m JP 72 10390, vol. 77, p. 500 (1972). |
Chemical Abstracts, 76325h JP 70 37523, vol. 74, p. 435 (1971). |
Blackburn et al., Bioorganic & Medicinal Chemistry Letters, vol. 4, No. 22, pp. 279-284 (1994). |
Bolton et al., Biorganic & Medicinal Chemistry Letters, vol. 3, No. 10, pp. 1941-1946 (1993). |
Chemical Abstracts, 140005v JP 72 36757, vol. 77, p. 445 (1972). |
Kanbe et al., Biosci. Biotech. Biochem ., vol. 57, No. 4, pp. 632-635 (1993). |
Continuation in Parts (2)
|
Number |
Date |
Country |
Parent |
509471 |
Jul 1995 |
|
Parent |
403357 |
Mar 1995 |
|